Background: Early detection of bacteria and their antibiotic susceptibility patterns are critical to guide therapeutic decision-making for optimal care of septic patients. The current gold standard, blood culturing followed by subculture on agar plates for subsequent identification, is too slow leading to excessive use of broad-spectrum antibiotic with harmful consequences for the patient and, in the long run, the public health. The aim of the present study was to assess the performance of two commercial assays, QuickFISHV R (OpGen) and Maldi Sepsityper TM (Bruker Daltonics) for early and accurate identification of microorganisms directly from positive blood cultures.
Introduction
Sepsis is the primary cause of death from severe infections. Globally, an estimated 18 million people die from sepsis annually [1] . Early sepsis diagnosis and targeted antimicrobial therapy can reduce the length of hospital stay of the patients and thereby decrease health care costs by approximately 30% [2] . The current gold standard for sepsis diagnosis, blood culturing, takes 12-72 h to detect microorganisms in the blood, and even longer to identify the specific organism and its antimicrobial susceptibility to be used for optimal therapy [3, 4] . Thus, there are demands for molecular assays that can easily be taken into the clinical microbiology laboratory routine handling, empowering earlier identification of the causative agent and its antibiogram. As the supplemented components in blood culture media, needed for antimicrobial neutralization are substituted with adsorbent polymeric beads, various molecular assays could improve by sampling directly from the positive blood culture, such as the matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and the peptide nucleic acid (PNA) fluorescent in situ hybridization (FISH) technique.
The PNA FISH method has been applied in clinical microbiology laboratories for over 15 years for identification of a variety of organisms using fluorescent PNA probes targeting the 16S rRNA of the bacteria and 18S rRNA for fungi [5] [6] [7] [8] . This technique requires prior Gram staining and subsequently the slide is viewed under a fluorescence microscope, turn-around time 1.5-3 h. Recent introduction of the next-generation test, the QuickFISH V R , the time for processing has been further reduced and the turn-around time is currently around 0.5 h. A number of different QuickFISH V R assays have been developed and validated, each capable of detecting up to a maximum of three different species per assay. Staphylococcus QuickFISH V R differentiates Staphylococcus aureus from coagulase-negative staphylococci (CoNS) [9] [10] [11] [12] , Enterococcus QuickFISH V R for identification of Gram-positive cocci in cluster differentiates Enterococcus faecalis from other Enterococcus spp., including Enterococcus faecium [12] [13] [14] , the Gram-Negative QuickFISH V R which differentiates Escherichia coli from Pseudomonas aeruginosa and Klebsiella pneumonia [12] , and finally the Candida QuickFISH V R assay differentiating Candida albicans from Candida glabrata and Candida parapsilosis [15] .
In contrast to QuickFISH V R , the MALDI-TOF MS theoretically has the potential to identify any cultured microorganism from a positive blood culture [16, 17] . Several methods for direct bacterial identification in positive blood cultures within 1 h with MALDI-TOF MS have been developed and recently summarized in a review by Dubourg et al [18] . Nevertheless, this application demands removal of human cells from the specimen to eliminate interference with human proteins in the final MALDI-TOF MS analysis. The commercial Maldi Sepsityper TM kit allows that, by involving the lysis of human blood cells, followed by centrifugation and washing steps. The final result is a pellet of bacteria or fungi, which is further processed by standard methods for species identification using MALDI-TOF MS [19] .
In the current study, we aim to extend our earlier evaluation [4] with two additional commercial assays, the Maldi Sepsityper TM and the QuickFISH V R assays for early and accurate identification of microorganisms directly from positive blood cultures. The commercial assays were compared to routine diagnostics at Unilabs, the clinical microbiology laboratory at Skaraborg Hospital, Sweden, by assessing concordance of identified microorganisms between the commercial assays and the reference method, identification rates as well as estimated turnaround times.
Material and methods

Settings
The Department of Clinical Microbiology, Unilabs AB, at Skaraborg Hospital, Sk€ ovde, Sweden, receives samples from all hospital departments, which in 2015 accounted for 12,000 blood culture bottles from 5000 patients.
Study design
The commercial assays were assessed against the reference method, described below. The present study was conducted as two substudies of positive blood cultures, February-March 2013 and April-May 2015. During the first substudy, a total of 179 positive blood culture bottles were identified in the clinical laboratory. To compare the identification rate, all positive blood cultures were analysed with the Maldi Sepsityper TM assay and routine analysis using the reference method ( Figure 1 ). For 100 of the 179 positive blood cultures, the reference method reported final species identification to the clinicians. Species identification of the Maldi Sepsityper TM assays directly on these 100 positive blood cultures were compared to the reported final species identification, to assess the performance of the Maldi Sepsityper TM assay.
By Gram staining of these 179 blood cultures, Grampositive cocci in cluster were identified and selected for species identification with either the Staphylococcus and/or Enterococcus QuickFISH V R assays. The assessment of the Gram-negative QuickFISH V R assay was performed during the second substudy, when 203 positive blood culture bottles were identified in the clinical laboratory. By Gram staining of these blood cultures, Gram-negative bacilli were identified and selected for species identification with the Gram-negative QuickFISH V R (Figure 1 ). To assess the performance of the QuickFISH V R assays, species identification by the QuickFISH V R was compared to species identification reported as final result by the reference method. The species identification by the reference method was performed without knowledge of the results using the two commercial assays. Turnaround times were estimated by the laboratory personnel performing the commercial assays and the reference method.
Reference method -routine diagnostics only one of these positive blood cultures bottles was further cultured on solid media. Definite species identification with MALDI-TOF MS was performed on a Microflex LT mass spectrometer (Bruker Daltonics, Leipzig, Germany) with BioTyper software v2.0 using default parameter settings. As recommended by Bruker Daltonics, spectral scores 2.0-2.29 was considered to be a high probability that the genus had been identified and the species was accurate. Spectral scores 1.7-1.99 was considered reliable for identification at the genus level. A score lower than 1.7 was considered as a negative result reported as 'no reliable identification'. The species or genus with the highest score was considered to be the identified organism in the sample and reported as final result in clinical routine. Antibiotic susceptibility was determined by accredited laboratory methods according to EUCAST guidelines (www.eucast. org). Preliminary results, i.e. species identification by MALDI-TOF MS and antibiotic susceptibility on isolates after a short incubation time on solid plates, were reported to clinicians within 6-7 h, whereas final results usually were reported to clinicians within 18-24 h. For this study, only the final results, i.e. final species identification and antibiotic susceptibility determined by the reference method, were used for comparison with the two commercial assays.
The QuickFISH V R assays were performed on aliquots taken from positive blood culture bottles removed from the automated blood culture system and stored at 4 C until sampling and Gram staining was performed, the same day or next morning. After the positive blood culture bottles had been given a code number, 10-15 droplets of the positive blood culture were transferred to an AdvanDx Filter Vial (OpGen, Gaithersburg, MD, United States). During the first substudy, Gram staining of positive blood cultures identifying Gram-positive cocci in cluster were selected for species identification with either the Staphylococcus and/or Enterococcus QuickFISH V R assays (OpGen, United States). The second substudy focused on the positive blood cultures where Gram staining identified Gram-negative bacilli for further species identification using the Gram-negative QuickFISH V R assay (OpGen, United States). The QuickFISH V R assays were performed according to the manufacturer s instructions, which also guided us to only analyse the first positive blood culture if more than one blood culture alerted (AdvanDx, 2014). The hybridized QuickFISH slides were immediately examined in a Leica DMR HC fluorescence microscope (Leica microsystems, Mannheim, Germany). The microscope had a 100X oil objective and was fitted with a dual-band filter (AC007 OpGen, United States). The QuickFISH slides include positive and negative controls that were read together with the clinical sample. The QuickFISH slides were read by eye independently by two different test operators.
Maldi sepsityper TM assay
During the first substudy, all positive blood cultures were analysed in parallel by both Maldi Sepsityper TM preparations methods, i.e. with or without extra formic acid treatment. The preparation of positive blood culture broths was performed according to the manufacturer's instructions (Bruker Daltonics, Leipzig, Germany). The collected pellet was either put directly on to the MALDI target plate (Bruker Daltonics, Germany) or the pellet was further processed following the Bruker standard extraction procedure including the extra formic acid step, with some minor modification. The pellet was mixed with 300 ll deionized water and 900 ll 99.5% ethanol (Histolab, Gothenburg, Sweden). The suspension was vortexed for 1 min and centrifuged at 14.000 rpm for 2 min. The supernatant was discarded and centrifuged for an additional 2 min and air-dried. Sequentially, 5-50 ll each of 70% formic acid (Sigma, St Louis, MO) and 100% acetonitrile (Sigma, USA) was added to the pellet, and thoroughly mixed after each reagent was added. The sample was vortexed for 10 s and left standing for 2 min. The sample was centrifuged again at 14.000 rpm for another 2 min, and 1 ll of the supernatant was spotted onto the steel target plate. After both procedures definite species identification with MALDI-TOF MS was performed as described above.
Data analysis
The results obtained from the Maldi Sepsityper TM assay with or without formic acid treatment, were compared to those obtained by the reference method. The spectral scores were assessed and compared as identification rate using the spectral cut-off scores, according to the reference method. The identification rate was also assessed and compared at spectral cut-off score < 1.5. Species identified directly from monomicrobial blood cultures with the commercial assays were compared with the final species identification of these cultured monomicrobial blood cultures, by the reference method. The following results were considered as correctly identified microorganism during the assessment: (i) true positive, an organism identified by the commercial method that was identified by the reference method and reported to clinician as a final result, (ii) true negative, an organism not identified by the commercial method and neither identified by the reference method, (iii) false negative, an organism not identified by the commercial method but was identified by the reference method and reported to clinician as a final result, and lastly (iv) false positive, an organism identified by the commercial method but was not identified by the reference method. Concordance of identified microorganisms between the commercial assays and reference method was calculated as the number of true positives and true negatives divided by the total number of organisms identified. Sensitivity was calculated as the number of true positives divided by the number of true positives and false negatives, whereas specificity was calculated as the number of true negatives divided by the number of true negatives and false positives. For calculation of binomial proportion confidence intervals, the Clopper-Pearson method was applied using the PropCIs package for R version 3.2.3 (R Foundation for Statistical Computing, Vienna, Austria).
Ethical statement
This study is a clinical laboratory benchmarking of two commercial kits. The study does not involve the collection or reporting of patient data, and no patient intervention occurred with the obtained results.
Results
Benchmarking of the maldi sepsityper TM kit with or without extra formic acid treatment
Identification rate
The reference method identified microorganism at score >2.0 in 89.1% (173/194) of the cultured bacterial isolates ( 
Performance against routine diagnostic
During the first substudy, routine diagnostics recognised 100 positive blood cultures to be further cultured on solid media for subsequent analysis using the reference method, which resulted in 92 monomicrobial cultures and seven mixed cultures, which were reported as polymicrobial cultures as final results in clinical routine (Table 2 ). Among these seven positive blood cultures, the Maldi Sepsityper TM assay identified one microorganism or no identification was obtained at all (Table 2 ). In addition, from one patient, the reference method identified C. albicans at spectral score 1. (Figure 1) .
Benchmarking of the QuickFISH V R assay
Performance against routine diagnostic
The first substudy assessed the Staphylococcus and/or Enterococcus QuickFISH 68.3-96.1) and a specificity of 100.0% (95% CI 54.1-100.0). In all, the concordance of identified species between the QuickFISH assays and the reference method was 94.8% (95% CI 88.4-98.3), 98.4% (95% CI 91.3-100.0) for the Staphylococcus and Enterococcus QuickFISH V R kit together, and 88.6% (95% CI 73.3-96.8)
for the Gram-Negative QuickFISH V R . The QuickFISH V R assay could report species identification after 1 h (Figure 1 ).
Discussion
Current composition of blood culture medium has facilitated analysis directly on samples from the positive blood culture bottles allowing earlier identification of the causative agent in bloodstream infections. In this study, we aimed to assess the performance of two different commercial blood culture identifications methods, the QuickFISH V R and Maldi Sepsityper TM assays, by comparing each commercial assay with routine analysis of bloodstream infections at a clinical microbiology laboratory. We assessed the degree of concordance of identified microorganisms between the commercial assays and the reference method, turnaround time and identification rate during two substudies. Our results indicate that the use of the commercial assays may shorten the time to identification of causative agents in bloodstream infections. Nevertheless, the performance of the commercial assays was considerable affected by the characteristics of the causative agents. At score >2.0, the reference method showed a satisfactory identification rate, identifying 92.2% (179/194) of the cultured isolates [20] compared to the rather low identification rate 34.6% (62/179) and 60.1% (109/179) using the Maldi Sepsityper TM kit without formic acid treatment or with formic acid treatment respectively (Table 1 ). Previous studies reported higher identification rates ranging from 67-100% [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] was superior at identifying Gram-negative to Grampositive bacteria (Table 3) . The QuickFISH V R assay showed no such preferences, rather the performance was dependent on whether the causative agent was covered by the assay. The overall high concordance between the QuickFISH V R assay and the reference method is consistent with other studies [9] [10] [11] [12] [13] , suggesting that QuickFISH
can provide a (Table 6 ). Another limitation of our study was that the majority of positive blood cultures tested with the Gram-Negative QuickFISH V R were positive for E. coli, thus we did not have the opportunity to fully assess the performance of the detection of other Gram-negatives. Even though no clear-cut answer has been provided on whether the prognosis of polymicrobial infections is worse than that of monomicrobial infections [34] , it can be observed that the identification of polymicrobial cultures was not possible using the Maldi Sepsityper TM assay, as well as the challenge of identifying fungal cultures, all in accordance with other studies [21, 25, 32] . A recent publication assessed an updated version of the Sepsityper module software able to detect mixed blood cultures through MALDI-TOF MS identification directly from a positive blood culture using the MALDI Sepsityper kit (Bruker Daltonik, Bremen, Germany). From 143 polymicrobial tested blood culture bottles, 34.3% (49/143) were completely identified by the module [35] .
Since QuickFISH V R assays are capable of detecting up to a maximum of three different species per assay, the assay is limiting the identification of all microorganisms in polymicrobial positive blood cultures, which has been observed earlier [12] . Early recognition of the causative agent represents an important factor influencing patient treatment and recovery [36] . Thus, the turnaround time is important to consider when assessing for identification of bloodstream pathogens. However, the time needed for species identification by conventional culture-based methods differs between clinical laboratories depending on routines. Though turnaround times were estimated and not precisely measured, our results point towards that the use of the commercial assays may shorten the time to identification of causative agents in bloodstream infections. The QuickFISH V R assay lead to a short turnaround time for pathogen identification, 1 h (Figure 1 ), which has also been reported earlier, including only five minutes hands-on time [9] [10] [11] 13] . The Maldi Sepsityper TM kit can be timesaving as well, but it needs more manual hands-on time. Furthermore, since the two commercial assays are used directly on positive blood cultures, the clinician could get the final species identification the same day as blood was withdrawn from the patient. Currently, it is not possible to use these commercial assays for antibiotic susceptibility testing in routine workflow, and therefore, culture of pure isolates is still needed for this purpose. However, there has been efforts to address this problem with MALDI-TOF MS applications detecting bacterial proteins involved in antibiotic resistance, such as the b-Lactamase enzyme [18, 37] .
Previous European studies focusing on direct costs per sepsis patient have yielded an estimated range from 23,000-42,000 EUR [2, 38, 39] . The major determinant of the direct costs is the length of stay in the hospital, clearly illustrating the potential savings in shortening the time to correct diagnosis of patients with bloodstream infection. A recent review has shown that the use of rapid diagnostic tests such as the PNA-FISH is a cost-effective strategy that was associated with high therapeutic effectiveness and health care cost savings [40] . In addition, it has been demonstrated that direct identification of organism in positive blood cultures bottles using MALDI-TOF MS or QuickFISH V R may have a clinical impact in patients with bacteraemia and improve appropriateness of antibiotic therapy [10, [41] [42] [43] .
Conclusion
The performance data of the assessed methods suggest that the use of a commercial assay may indeed be a good addition to the current routine laboratory diagnostics for an earlier but still sufficiently accurate identification of microorganisms directly from positive blood culture bottles. Based on the result from this study, we suggest a workflow where the current Gram stain could guide the choice of downstream species identification methodology. The polymicrobial -, as well as the fungal -, blood cultures should still be analysed only by the reference method. Considering monomicrobial Gramnegative cultures, the Maldi Sepsityper TM assay may well deliver the correct species identification earlier than the reference method. As Gram-positive cocci in cluster is currently the most commonly encountered bacterial morphotype in positive blood cultures [33] , the Staphylococcus QuickFISH V R can serve as a complement to the reference method, enable the laboratory to accurately differentiating S. aureus from CoNS in blood cultures in 1 h.
